Automation Workflow for Proactive Medication Adherence Support

This workflow automates the costly, manual process of identifying and intervening with non-adherent patients. By integrating with pharmacy benefit manager (PBM) claims feeds and EHRs, it monitors prescription fill patterns in real-time, calculates adherence scores (e.g., PDC), and triggers personalized, multi-channel nudges. The operational upside comes from reducing preventable hospitalizations, improving Star Ratings for managed care plans, and freeing clinical staff from routine follow-up calls, directly impacting pharmacy revenue and patient health outcomes.

Implementation requires a rules engine for nudge logic (e.g., timing, channel, message personalization) and integration with pharmacy management systems like PioneerRx or QS/1. Critical controls include configurable escalation paths to human pharmacists, audit trails for interventions, and consent management for communications. The architecture must handle data quality exceptions from fragmented claims data and support gradual rollout by patient cohort or therapy class to manage operational risk.

This workflow automates the high-volume, repetitive task of monitoring prescription fill patterns and initiating personalized patient outreach. The operational upside comes from intercepting non-adherence before it escalates into costly hospitalizations or complications, directly improving chronic care management margins. Savings are realized through reduced pharmacist and nurse intervention time and better medication persistence, which drives positive health outcomes and associated financial performance for value-based care contracts.

Implementation requires integrating with PBM APIs (e.g., Express Scripts, CVS Caremark) and pharmacy management systems to ingest real-time fill data. The orchestrator, built on frameworks like LangGraph, routes patients through a logic engine that applies clinical rulesets. Controls include approval gates for high-risk escalations, audit trails for all nudges, and continuous model monitoring to refine behavioral prediction accuracy. The architecture must support HIPAA-compliant messaging channels and bidirectional EHR updates for a closed-loop system.

Phase 1 establishes the core data pipeline and alerting foundation. We integrate with the Pharmacy Benefit Manager (PBM) or pharmacy management system via API to ingest real-time prescription fill and refill data. This data is normalized and stored, triggering baseline logic to flag missed refill windows. Initial alerts are routed to a centralized dashboard for pharmacist review, creating a closed feedback loop to validate data quality and exception handling before full automation. This phase delivers immediate visibility into adherence gaps.

Phase 2 introduces the AI orchestration layer and scales interventions. The Adherence Logic Engine, built on a framework like LangGraph, evaluates patient history, preferred channels, and behavioral triggers to execute multi-step nudge sequences (SMS, IVR, patient portal). Patients responding positively are looped back for positive reinforcement. Persistent non-adherence is automatically routed with context to a clinical triage queue within the EHR (e.g., Epic, Cerner) for pharmacist or nurse intervention. Phase 3 focuses on optimization, adding predictive modeling for future risk and integrating outcomes data to measure ROI in reduced hospitalizations and improved A1c/LDL control.

The operational upside—reduced hospitalizations, improved star ratings, and optimized pharmacist labor—depends on a workflow that integrates PBM claims feeds, EHR medication lists, and patient communication channels with deterministic control logic. Governance begins with data validation: claims are reconciled against NDC databases and patient profiles to prevent false non-adherence flags. Approval gates are required before any clinical intervention is triggered, ensuring a pharmacist or nurse reviews the patient's full context, including recent hospitalizations or palliative care status, before outreach is initiated.

Phased rollout mitigates risk and validates logic. Phase 1 targets a single chronic condition (e.g., hypertension) and a low-risk patient cohort, deploying read-only monitoring and simulated nudges to tune the adherence algorithm without live patient impact. Phase 2 introduces human-in-the-loop approval for all outbound communications, with interventions logged in the pharmacy management system for audit. Phase 3 scales to multiple conditions and enables autonomous, rule-based nudges for low-risk patterns, while maintaining high-risk escalations. Each phase is governed by weekly reviews of false-positive rates, patient opt-outs, and pharmacist workload impact.

This custom workflow automates the costly, reactive cycle of managing medication non-adherence. It ingests real-time fill data from PBM systems like Express Scripts or CVS Caremark, applies behavioral models to predict lapses, and orchestrates multi-channel nudges—SMS, IVR, patient portal—before a missed refill becomes a clinical event. The operational upside comes from reducing hospitalizations and ER visits, directly protecting margin for value-based care contracts and improving star ratings. Implementation requires integrating with pharmacy claims feeds, a rules engine for intervention logic, and patient communication platforms.

The architecture's control plane is the Exception Router, which classifies gaps (e.g., 7-day lapse on anticoagulant) and routes to the appropriate human-in-the-loop—a pharmacist for therapy questions or a nurse for side effects—within platforms like Epic or Oracle Cerner. Governance requires audit trails for all interventions, configurable approval thresholds, and continuous model monitoring for prediction drift. Rollout is sequenced by therapeutic area, starting with high-cost chronic conditions like diabetes or hypertension, to validate efficacy and refine nudge logic before scaling across the patient population.